Screening accuracy of Single-Point Insulin Sensitivity Estimator (SPISE) for metabolic syndrome: a systematic review and meta-analysis

Screening accuracy of Single-Point Insulin Sensitivity Estimator (SPISE) for metabolic syndrome: a systematic review and meta-analysis

Abstract Background Metabolic syndrome (MetS) is a multifactorial condition linked to increased risk of cardiovascular disease and type 2 diabetes. The Single-Point Insulin Sensitivity Estimator (SPISE), a non-invasive index calculated via 600 × HDL-C^0.185 / (TG^0.2 × BMI^1.338), offers a practical...

Full description

Saved in:
Bibliographic Details
Main Authors: Alireza Azarboo, Parisa Fallahtafti, Sayeh Jalali, Amirhossein Shirinezhad, Ramin Assempoor, Amirhossein Ghaseminejad-Raeini
Format: Article
Language:English
Published: BMC 2025-06-01
Series:BMC Endocrine Disorders
Subjects:
Metabolic syndrome
Single-Point Insulin Sensitivity Estimator
Insulin resistance
Meta-analysis
Online Access:https://doi.org/10.1186/s12902-025-01957-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12902-025-01957-6

Similar Items